GlassScriptPhysician profile
Edward Ray
NPI 1184808438
$30,643.07
in general payments reported to CMS, 2019-2025
21 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $237 · 2021: $1,938 · 2022: $4,309 · 2023: $1,719 · 2024: $1,921 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Consulting Fee: $7,530 · Food and Beverage: $4,281 · Travel and Lodging: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,100.00 |
| Consulting Fee | $7,530.00 |
| Food and Beverage | $4,281.16 |
| Travel and Lodging | $722.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11,100.00 | 2025 | |
| Ethicon INC. | $7,332.29 | 2025 | |
| Sientra, INC. | $4,710.54 | 2019-2022 | |
| Rti Surgical, INC | $1,862.30 | 2021-2025 | |
| Integra Lifesciences Corporation | $1,722.85 | 2019-2025 | Surgimend, Codman Certas, Integra |
| Polynovo North America LLC | $1,390.98 | 2022-2024 | Novosorb Btm |
| Tela Bio, INC. | $858.79 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $434.96 | 2019-2022 | |
| Mentor Worldwide LLC | $271.14 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $234.59 | 2019-2021 | |
| Davol INC. | $155.40 | 2025 | Phasix Mesh |
| Innovation Technologies INC | $97.76 | 2022 | |
| Tepha INC | $83.54 | 2019-2020 | |
| Olympus America INC. | $81.23 | 2019 | |
| Biocircuit Technologies INC | $62.97 | 2025 | Nerve Tape |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Microinstruments, INC. | $58.42 | 2024 | Symani Surgical Systems |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Becton, Dickinson and Company | $39.58 | 2025 | Phasix Mesh |
| Vioptix INC | $35.29 | 2020 | |
| Baxter Healthcare | $31.74 | 2020 | |
| Abbvie INC. | $28.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.